Vascular comorbidities in familial Mediterranean fever

scientific article published on 25 March 2011

Vascular comorbidities in familial Mediterranean fever is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1007/S00296-011-1845-7
P698PubMed publication ID21437693

P2093author name stringZ Birsin Ozçakar
Fatoş Yalçınkaya
P2860cites workClinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutationsQ24300638
Colchicine as first-choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trialQ28192176
Effect of colchicine (0.5 mg twice daily) on high-sensitivity C-reactive protein independent of aspirin and atorvastatin in patients with stable coronary artery diseaseQ28220518
Arterial distensibility in chronic inflammatory rheumatic disordersQ30481548
Amyloid cardiomyopathy in systemic non-hereditary amyloidosis. Clinical, echocardiographic and electrocardiographic findings in 30 patients with AA and 24 patients with AL amyloidosisQ68183594
Electrocardiography and Doppler echocardiography in secondary (AA) amyloidosisQ71015688
Familial Mediterranean feverQ74309346
[The periodic disease]Q76299469
Familial mediterranean fever and acute myocardial infarction secondary to coronary vasculitisQ77376866
Familial Mediterranean feverQ78259596
Vasculitis in childhoodQ78374018
Are familial Mediterranean fever (FMF) patients at increased risk for atherosclerosis? Impaired endothelial function and increased intima media thickness are found in FMFQ79425845
Vasculitis in childrenQ81632385
The rationale for comparative studies of accelerated atherosclerosis in rheumatic diseasesQ84565393
Cardiovascular reactivity score for the assessment of dysautonomia in familial Mediterranean feverQ33149792
Behçet's Disease: an Insight from a Cardiologist's Point of View.Q33760174
Colchicine for familial Mediterranean feverQ34052599
Identification of MEFV-independent modifying genetic factors for familial Mediterranean feverQ34146734
Advances in the understanding of familial Mediterranean fever and possibilities for targeted therapyQ34608120
Natural history and outcome in systemic AA amyloidosisQ34635240
Amyloidosis induced, end stage renal disease in patients with familial Mediterranean fever is highly associated with point mutations in the MEFV geneQ35550032
Acute phase response in familial Mediterranean feverQ35550951
Familial Mediterranean fever gene (MEFV) mutations in patients with rheumatic heart diseaseQ35580006
MEFV mutation carriers and diseases other than familial Mediterranean fever: proved and non-proved associations; putative biological advantageQ36048204
Colchicine use in children and adolescents with familial Mediterranean fever: literature review and consensus statementQ36714926
Cardiovascular co-morbidity in rheumatic diseasesQ36835851
The carotid-femoral (aortic) pulse wave velocity as a marker of arterial stiffness in familial Mediterranean fever.Q36940783
Familial Mediterranean fever: clinical, molecular and management advancementsQ36978762
Behçet's Disease as a Model of Venous Thrombosis.Q37723289
Epidemiology of vasculitisQ37926353
MEFV mutations in Behçet's diseaseQ39531018
Familial mediterranean Fever as an emerging clinical model of atherogenesis associated with low-grade inflammation.Q39845776
The effect of colchicine on physical growth in children with familial mediterranean feverQ40371346
Intima-media thickening in patients with familial Mediterranean feverQ40388612
Platelet activation in patients with Familial Mediterranean Fever.Q40407167
MEFV mutations modify the clinical presentation of Henoch-Schönlein purpuraQ40407587
Assessment of aortic stiffness and ventricular functions in familial Mediterranean fever.Q40412909
Evaluation of intima media thickness of the common and internal carotid arteries with inflammatory markers in familial Mediterranean fever as possible predictors for atherosclerosisQ40418469
Assessment of aortic wall stiffness in patients with Familial Mediterranean FeverQ40423322
Prevalence of the MEFV gene mutations in childhood polyarteritis nodosaQ40433800
The evaluation of carotid intima-media thickness in children with familial Mediterranean feverQ40437279
Impaired coronary microvascular function in familial Mediterranean feverQ40442871
Country as the primary risk factor for renal amyloidosis in familial Mediterranean fever.Q40451318
Common FMF alleles may predispose to development of Behcet's disease with increased risk for venous thrombosis.Q40451781
Early ultrasonographic markers of atherosclerosis in patients with familial Mediterranean fever.Q40459503
Role of the pyrin M694V (A2080G) allele in acute myocardial infarction and longevity: a study in the Sicilian population.Q40489689
Possible effect of subclinical inflammation on daily life in familial Mediterranean feverQ40498320
Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter studyQ40517425
MEFV mutations are increased in Behçet's disease (BD) and are associated with vascular involvement.Q40542090
A case of familial Mediterranean fever and polyarteritis nodosa complicated by spontaneous perirenal and subcapsular hepatic hemorrhage requiring multiple arterial embolizationsQ40542578
Prevalence and significance of mutations in the familial Mediterranean fever gene in Henoch-Schönlein purpuraQ40546130
A retrospective analysis for aetiology and clinical findings of 287 secondary amyloidosis cases in TurkeyQ40572115
Antistreptococcal response is exaggerated in children with familial Mediterranean feverQ40575145
Familial mediterranean fever and Behçet's disease--are they associated?Q40586138
Familial Mediterranean fever (FMF)-associated amyloidosis in childhood. Clinical features, course and outcomeQ40591426
Cardiac and intestinal amyloidosis in a renal transplant recipient with familial Mediterranean feverQ40601320
Prevalence of ischemic heart disease in patients with familial Mediterranean fever.Q40603169
Polyarteritis nodosa in patients with Familial Mediterranean Fever (FMF): a concomitant disease or a feature of FMF?Q40608723
The gene for familial Mediterranean fever, MEFV, is expressed in early leukocyte development and is regulated in response to inflammatory mediators.Q40621671
Clinical, laboratory and molecular characteristics of children with Familial Mediterranean Fever-associated vasculitisQ40625160
Familial Mediterranean fever and acute rheumatic fever: a pathogenetic relationship?Q40627428
Vasculitis in familial Mediterranean feverQ40656391
The changing face of familial Mediterranean feverQ40660571
Familial Mediterranean fever in Turkey. A report of twenty casesQ40927013
The role of amyloidosis in familial mediterranean fever. A population studyQ40945196
Transplantation in renal amyloidosis.Q44475559
Rapid onset of muscle weakness (rhabdomyolysis) associated with the combined use of simvastatin and colchicineQ46961985
Familial Mediterranean fever.Q53649569
Familial Mediterranean fever - renal involvement by diseases other than amyloidQ62937812
P433issue10
P921main subjectcomorbidityQ1414874
P304page(s)1275-1281
P577publication date2011-03-25
P1433published inRheumatology InternationalQ15763689
P1476titleVascular comorbidities in familial Mediterranean fever
P478volume31

Reverse relations

cites work (P2860)
Q91672485Canakinumab: can it untie the Gordian knot of cardiovascular disease in patients with familial Mediterranean fever?
Q47672352Cardiovascular disease in patients with autoinflammatory syndromes
Q35773615Cholesterol, Inflammasomes, and Atherogenesis
Q40144808Ischemia-Modified Albumin and Atherosclerosis in Patients With Familial Mediterranean Fever
Q26783517Non-thrombocytopenic purpura in familial Mediterranean fever-comorbidity with Henoch-Schönlein purpura or an additional rare manifestation of familial Mediterranean fever?
Q40064657Retinal and Choroidal Thickness in Adult Patients with Familial Mediterranean Fever.
Q40204294Retinal and choroidal thickness in children with familial Mediterranean fever
Q36664121Roles of heat-shock protein 70 in protecting against intestinal mucosal damage
Q91953073The Platelet-to-Lymphocyte Ratio as an Inflammatory Marker in Rheumatic Diseases
Q40176395Vasculitis and long standing ankylosing spondylitis in a patient with familial Mediterranean fever.

Search more.